FDG-PET Follow-up of Non-Small Cell Lung Cancer: Not Dead Yet

被引：3
|
作者：
Stirling, Rob G. [1 ]
Zalcberg, John [1 ]
机构：
[1] Monash Univ, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
来源：
ANNALS OF THORACIC SURGERY | 2020年 / 109卷 / 05期
关键词：
D O I：
10.1016/j.athoracsur.2019.05.042
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1624 / 1624
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study
    Paul Verboom
    Harm van Tinteren
    Otto S. Hoekstra
    Egbert F. Smit
    Jan H. A. M. van den Bergh
    Ad J. M. Schreurs
    Roland A. L. M. Stallaert
    Piet C. M. van Velthoven
    Emile F. I. Comans
    Fred W. Diepenhorst
    Johan C. van Mourik
    Pieter E. Postmus
    Maarten Boers
    Els W. M. Grijseels
    Gerrit J. J. Teule
    Carin A. Uyl-de Groot
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 1444 - 1449
  • [42] FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence
    Croft, DR
    Trapp, J
    Kernstine, K
    Kirchner, P
    Mullan, B
    Galvin, J
    Peterson, MW
    Gross, T
    McLennan, G
    Kern, JA
    LUNG CANCER, 2002, 36 (03) : 297 - 301
  • [43] Pretreatment FDG-PET SUVmax is not a prognostic marker in stage IV non-small cell lung cancer
    Clausen, Malene
    Brittain, Jane
    Loft, Annika
    Langer, Seppo
    Kjaer, Andreas
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [44] Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study
    Verboom, P
    van Tinteren, H
    Hoekstra, OS
    Smit, EF
    van den Bergh, JHAM
    Schreurs, AJM
    Stallaert, RALM
    van Velthoven, PCM
    Comans, EFI
    Diepenhorst, FW
    van Mourik, JC
    Postmus, PE
    Boers, M
    Grijseels, EWM
    Teule, GJJ
    Uyl-de Groot, CA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (11) : 1444 - 1449
  • [45] How effective is FDG-PET in the locoregional lymph node staging of non-small cell lung cancer?
    Türkmen, C
    Yilmazbayhan, D
    Erelel, M
    Halaç, M
    Ece, T
    Durgun, E
    Güllüoglu, M
    Selçuk, NA
    Kalayci, G
    Sönmezoglu, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S350 - S350
  • [46] FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer
    Hoopes, D
    Tann, M
    McGarry, R
    Lo, S
    Timmerman, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S225 - S225
  • [47] Non-small cell lung cancer in the new millennium: The effect of FDG-PET on stage distribution.
    Goodgame, B.
    Morgensztern, D.
    Grove, L.
    Govindan, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 415S - 415S
  • [48] Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: Analysis of false-positive FDG-PET findings
    Konishi, J
    Yamazaki, K
    Tsukamoto, E
    Tamaki, N
    Onodera, Y
    Otake, T
    Morikawa, T
    Kinoshita, I
    Dosaka-Akita, H
    Nishimura, M
    RESPIRATION, 2003, 70 (05) : 500 - 506
  • [49] FDG-PET imaging in the management of non-small-cell lung cancer
    Salminen, E
    Mac Manus, M
    ANNALS OF ONCOLOGY, 2002, 13 (03) : 357 - 360
  • [50] Small cell lung cancer: role of FDG-PET and PET/CT
    Baum, R. R.
    Prasad, V.
    ONKOLOGE, 2008, 14 (08): : 774 - +
12345